149 related articles for article (PubMed ID: 24790146)
1. The ligand-binding domain of Siglec-G is crucial for its selective inhibitory function on B1 cells.
Hutzler S; Özgör L; Naito-Matsui Y; Kläsener K; Winkler TH; Reth M; Nitschke L
J Immunol; 2014 Jun; 192(11):5406-14. PubMed ID: 24790146
[TBL] [Abstract][Full Text] [Related]
2. CD22 x Siglec-G double-deficient mice have massively increased B1 cell numbers and develop systemic autoimmunity.
Jellusova J; Wellmann U; Amann K; Winkler TH; Nitschke L
J Immunol; 2010 Apr; 184(7):3618-27. PubMed ID: 20200274
[TBL] [Abstract][Full Text] [Related]
3. Siglec-G is a B1 cell-inhibitory receptor that controls expansion and calcium signaling of the B1 cell population.
Hoffmann A; Kerr S; Jellusova J; Zhang J; Weisel F; Wellmann U; Winkler TH; Kneitz B; Crocker PR; Nitschke L
Nat Immunol; 2007 Jul; 8(7):695-704. PubMed ID: 17572677
[TBL] [Abstract][Full Text] [Related]
4. CD22 and Siglec-G: B-cell inhibitory receptors with distinct functions.
Nitschke L
Immunol Rev; 2009 Jul; 230(1):128-43. PubMed ID: 19594633
[TBL] [Abstract][Full Text] [Related]
5. Copresentation of antigen and ligands of Siglec-G induces B cell tolerance independent of CD22.
Pfrengle F; Macauley MS; Kawasaki N; Paulson JC
J Immunol; 2013 Aug; 191(4):1724-31. PubMed ID: 23836061
[TBL] [Abstract][Full Text] [Related]
6. Sialic Acid Ligand Binding of CD22 and Siglec-G Determines Distinct B Cell Functions but Is Dispensable for B Cell Tolerance Induction.
Özgör L; Meyer SJ; Korn M; Terörde K; Nitschke L
J Immunol; 2018 Oct; 201(7):2107-2116. PubMed ID: 30143587
[TBL] [Abstract][Full Text] [Related]
7. Siglec-G is a B-1 cell inhibitory receptor and also controls B cell tolerance.
Nitschke L
Ann N Y Acad Sci; 2015 Dec; 1362():117-21. PubMed ID: 26194636
[TBL] [Abstract][Full Text] [Related]
8. Siglec-G Deficiency Leads to Autoimmunity in Aging C57BL/6 Mice.
Müller J; Lunz B; Schwab I; Acs A; Nimmerjahn F; Daniel C; Nitschke L
J Immunol; 2015 Jul; 195(1):51-60. PubMed ID: 25987743
[TBL] [Abstract][Full Text] [Related]
9. CD22 and Siglec-G regulate inhibition of B-cell signaling by sialic acid ligand binding and control B-cell tolerance.
Nitschke L
Glycobiology; 2014 Sep; 24(9):807-17. PubMed ID: 25002414
[TBL] [Abstract][Full Text] [Related]
10. Siglec-G regulates B1 cell survival and selection.
Jellusova J; Düber S; Gückel E; Binder CJ; Weiss S; Voll R; Nitschke L
J Immunol; 2010 Sep; 185(6):3277-84. PubMed ID: 20729333
[TBL] [Abstract][Full Text] [Related]
11. Siglec-G deficiency leads to more severe collagen-induced arthritis and earlier onset of lupus-like symptoms in MRL/lpr mice.
Bökers S; Urbat A; Daniel C; Amann K; Smith KG; Espéli M; Nitschke L
J Immunol; 2014 Apr; 192(7):2994-3002. PubMed ID: 24600033
[TBL] [Abstract][Full Text] [Related]
12. Ligand Recognition Determines the Role of Inhibitory B Cell Co-receptors in the Regulation of B Cell Homeostasis and Autoimmunity.
Tsubata T
Front Immunol; 2018; 9():2276. PubMed ID: 30333834
[TBL] [Abstract][Full Text] [Related]
13. Differentially regulated expression and function of CD22 in activated B-1 and B-2 lymphocytes.
Lajaunias F; Nitschke L; Moll T; Martinez-Soria E; Semac I; Chicheportiche Y; Parkhouse RM; Izui S
J Immunol; 2002 Jun; 168(12):6078-83. PubMed ID: 12055217
[TBL] [Abstract][Full Text] [Related]
14. B Cell Siglecs-News on Signaling and Its Interplay With Ligand Binding.
Meyer SJ; Linder AT; Brandl C; Nitschke L
Front Immunol; 2018; 9():2820. PubMed ID: 30559744
[TBL] [Abstract][Full Text] [Related]
15. The ligand interactions of B cell Siglecs are involved in the prevention of autoimmunity to sialylated self-antigens and in the quality control of signaling-competent B cells.
Tsubata T
Int Immunol; 2023 Oct; 35(10):461-473. PubMed ID: 37504378
[TBL] [Abstract][Full Text] [Related]
16. Murine Red Blood Cells Lack Ligands for B Cell Siglecs, Allowing Strong Activation by Erythrocyte Surface Antigens.
Spiller F; Nycholat CM; Kikuchi C; Paulson JC; Macauley MS
J Immunol; 2018 Feb; 200(3):949-956. PubMed ID: 29288201
[TBL] [Abstract][Full Text] [Related]
17. Sialic Acid-Binding Immunoglobulin-like Lectin G Promotes Atherosclerosis and Liver Inflammation by Suppressing the Protective Functions of B-1 Cells.
Gruber S; Hendrikx T; Tsiantoulas D; Ozsvar-Kozma M; Göderle L; Mallat Z; Witztum JL; Shiri-Sverdlov R; Nitschke L; Binder CJ
Cell Rep; 2016 Mar; 14(10):2348-61. PubMed ID: 26947073
[TBL] [Abstract][Full Text] [Related]
18. Signaling through murine CD38 is impaired in antigen receptor-unresponsive B cells.
Lund FE; Solvason NW; Cooke MP; Health AW; Grimaldi JC; Parkhouse RM; Goodnow CC; Howard MC
Eur J Immunol; 1995 May; 25(5):1338-45. PubMed ID: 7774637
[TBL] [Abstract][Full Text] [Related]
19. Siglec-7 tetramers characterize B-cell subpopulations and leukemic blasts.
Gieseke F; Mang P; Viebahn S; Sonntag I; Kruchen A; Erbacher A; Pfeiffer M; Handgretinger R; Müller I
Eur J Immunol; 2012 Aug; 42(8):2176-86. PubMed ID: 22585296
[TBL] [Abstract][Full Text] [Related]
20. Decoration of T-independent antigen with ligands for CD22 and Siglec-G can suppress immunity and induce B cell tolerance in vivo.
Duong BH; Tian H; Ota T; Completo G; Han S; Vela JL; Ota M; Kubitz M; Bovin N; Paulson JC; Nemazee D
J Exp Med; 2010 Jan; 207(1):173-87. PubMed ID: 20038598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
